Fecal Microbiota Transplantation for Recurrent Clostridioides difficile infection: The COVID-19 Era
Sahil Khanna, Darrell S. Pardi
Abstract
1C. difficile clinic and Microbial Replacement Therapy program, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA. Correspondence: Sahil Khanna, MBBS, MS. E-mail: [email protected].
Topics & Concepts
ClostridioidesFecal bacteriotherapyHepatologyMedicineInternal medicineC difficileCoronavirus disease 2019 (COVID-19)FecesTransplantationClostridium difficileGastroenterologyMicrobiologyBiologyAntibioticsInfectious disease (medical specialty)DiseaseClostridium difficile and Clostridium perfringens researchMicroscopic ColitisGastrointestinal motility and disorders